MedPath

BRM-421

Generic Name
BRM-421
Drug Type
Biotech

Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment

Phase 2
Completed
Conditions
Dry Eye Syndrome
Interventions
Drug: Placebo
First Posted Date
2020-04-13
Last Posted Date
2021-10-21
Lead Sponsor
BRIM Biotechnology Inc.
Target Recruit Count
220
Registration Number
NCT04343287
Locations
🇺🇸

Eye Research Foundation, Newport Beach, California, United States

🇺🇸

Midwest Cornea Associates, LLC, Indianapolis, Indiana, United States

🇺🇸

Andover Eye Associates, Andover, Massachusetts, United States

and more 1 locations

Safety and Efficacy of BRM421 for Dry Eye Syndrome

Phase 2
Completed
Conditions
Dry Eye Syndrome
Interventions
Drug: Placebo
First Posted Date
2017-02-28
Last Posted Date
2017-11-22
Lead Sponsor
BRIM Biotechnology Inc.
Target Recruit Count
157
Registration Number
NCT03066219
Locations
🇺🇸

Andover Eye Associates, Andover, Massachusetts, United States

🇺🇸

Central Maine Eye Care, Lewiston, Maine, United States

© Copyright 2025. All Rights Reserved by MedPath